Jury finds Insmed infringes IGF-1 patents
INSM fell $0.28 (18%) to $1.31 on 8.5 million shares on Wednesday after a jury in the U.S. District Court for the
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
INSM fell $0.28 (18%) to $1.31 on 8.5 million shares on Wednesday after a jury in the U.S. District Court for the